| | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H17N |
| Molar mass | 163.264 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3-Methylmethamphetamine (3-MMA) or Metaphedrine is an amphetamine derivative which has been sold as a designer drug, first being reported in Sweden in 2021. [1] It is a potent monoamine reuptake inhibitor. [2] The drug was not active as a serotonin 5-HT2A receptor agonist. [2]
{{cite book}}: CS1 maint: DOI inactive as of July 2025 (link)| | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |